Successful treatment of multiple vemurafenib-induced keratoacanthomas by topical application of imiquimod cream: Confirmation of clinical clearance by dermoscopy

Do Young RheeDepartment of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea

Kwang Hee WonDepartment of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea

Ye Jin LeeDepartment of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea

Chong Hyun WonDepartment of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea

Sung Eun ChangDepartment of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea

Mi Woo LeeDepartment of Dermatology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, KoreaCorrespondence[email protected]

References

Alloo A, Garibyan L, LeBoeuf N, et al. Photodynamic therapy for multiple eruptive keratoacanthomas associated with vemurafenib treatment for metastatic melanoma. Arch Dermatol. 2012;148:363–6.
PubMedGoogle Scholar
Chu EY, Wanat KA, Miller CJ, et al. Diverse cutaneous side effects associated with BRAF inhibitor therapy: a clinicopathologic study. J Am Acad Dermatol. 2012;67:1265–72.
PubMed Web of Science ®Google Scholar
Boussemart L, Routier E, Mateus C, et al. Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients. Ann Oncol. 2013;24:1691–7.
PubMed Web of Science ®Google Scholar
Jeon HC, Choi M, Paik SH, et al. Treatment of keratoacanthoma with 5% imiquimod cream and review of the previous report. Ann Dermatol. 2011;23:357–61.
PubMed Web of Science ®Google Scholar
Calista D, Morri M. Topical imiquimod for the treatment of keratoacanthomas. Eur J Dermatol. 2008;18:590–1.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Successful treatment of multiple vemurafenib-induced keratoacanthomas by topical application of imiquimod cream: Confirmation of clinical clearance by dermoscopy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Successful treatment of multiple vemurafenib-induced keratoacanthomas by topical application of imiquimod cream: Confirmation of clinical clearance by dermoscopy

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date